Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy - Ladbury, Colton J.; Rusthoven, Chad G.; Camidge, D. Ross; Kavanagh, Brian D.; Nath, Sameer K. (International journal of radiation oncology, biology, physics, 2019)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Carcinoma, Non-Small-Cell Lung - immunology; Carcinoma, Non-Small-Cell Lung - mortality; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Non-Small-Cell Lung - therapy; Chemoradiotherapy - adverse effects; Chemoradiotherapy - methods; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Female; Heart - radiation effects; Humans; Immune System - radiation effects; Immunity, Cellular - radiation effects; Kaplan-Meier Estimate; Leukocyte Count; Lung - radiation effects; Lung Neoplasms - immunology; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lung Neoplasms - therapy; Lymphocytes - radiation effects; Lymphopenia - etiology; Male; Middle Aged; Multivariate Analysis; Neutropenia - etiology; Neutrophils - radiation effects; Organs at Risk - radiation effects; Progression-Free Survival; Proportional Hazards Models; Radiation Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies